EpiPen 0.3mg Auto-Injectors have Longer Shelf Life
15th November 2019
EpiPen 0.3mg auto-injector devices have now had their shelf life increased from 20 months to 24 months from the date of manufacture. Expiry dates can be found on the label on the auto-injector device and should not be used after this date. The shelf life for EpiPen 0.15mg auto-injector devices remains at 19 months from […]
Read More...
Latest NHS Digital figures show an increase in anaphylaxis hospital admissions in children and adults
15th November 2019
Latest figures reveal that hospital admissions for anaphylactic shock for all causes has risen by around 70% in the past five years, from 2013-2014 to 2018-2019, for under 18s, as shown in the graph below. Hospital admissions for anaphylactic shock for adults has also increased from 3,092 to 3,751 in the same five-year period. See […]
Read More...
Statement Regarding the Death of Dennis Walsh
6th November 2019
The Anaphylaxis Campaign is saddened to learn of the death of Dennis Walsh, a 70-year-old who died due to a severe anaphylactic reaction to the contrast dye used during a CT scan on 8 August 2019 at Royal Blackburn Hospital. An inquest into his death held at Blackburn Town Hall on 30 October heard that […]
Read More...
IMPORTANT UPDATE: UK Supply of Imported Jext® 300mcg Adrenaline Auto-Injectors from Austria
24th October 2019
We have received the following statement from ALK regarding imported Jext® 300mcg Adrenaline Auto-Injectors from Austria which aim to support and maintain the overall supply in the UK market. There are supply issues affecting some brands of adrenaline auto-injectors on the UK market. To support and maintain an overall adequate supply, ALK has obtained acceptance from […]
Read More...
Supply Status of Emerade Adrenaline Auto-Injectors in the UK – Statement from Bausch + Lomb
14th October 2019
14th October 2019 We have received the following statement from Bausch + Lomb regarding the supply status of AAIs: Bausch + Lomb is committed to helping ensure that patients have access to the medicines they need, and we are working diligently to help supply the market with this critical medicine. Over the last year we […]
Read More...
New Allergy Labelling Rules – Update from the FSA
8th October 2019
8th October 2019 Information on the scope of the new Allergy Labelling legislation was scheduled to be published by the FSA on the 1st October 2019 but due to Industry stakeholders raising further questions concerning the new rules, the FSA have decided to defer issuing information on the scope of the new legislation in order […]
Read More...
MHRA Issues Device Alert for Emerade
3rd October 2019
Thursday 3rd October 2019 The Medicines & Healthcare products Regulatory Agency (MHRA) has received reports of Emerade pens failing to activate. This means that the needle is not released, and the injection is not delivered. This is different from the needle blockage issue that you are likely to have been informed about previously by your […]
Read More...
IMPORTANT UPDATE: Extended Use-by Period for Specific Lots of Jext® 150mcg and 300mcg Adrenaline Auto-Injectors
2nd October 2019
To support and maintain an overall adequate supply, ALK has obtained acceptance from the UK medicines regulator, MHRA, to extend the use of specific lot (batch) numbers of Jext® 150 mcg and Jext® 300 mcg auto-injectors, beyond the labelled expiry date by four months. The affected lot numbers are listed in the link below. Click […]
Read More...
IMPORTANT UPDATE: Extended Use-by Period for Specific Lots of EpiPen® 0.3mg Adrenaline Auto-Injectors
30th September 2019
Mylan UK have obtained acceptance from the MHRA to extend the use of specific lot numbers of EpiPen® 0.3mg auto-injectors, by 4 months beyond the labelled expiry date. The affected lot numbers are listed in the link below. Click here to see the affected lot numbers Important: The extended use only applies to the lots […]
Read More...
Adrenaline Auto-Injector Supply Update – Instructions for Schools
24th September 2019
The following information has been taken from Mylan’s September 2019 EpiPen® supply statement. Click here to read the full statement To support children and young adults who may be at risk of anaphylaxis whilst away from home, the Human Medicines (Amendment) Regulations 2017 allows schools, without the need for a prescription, to purchase and […]
Read More...